首页> 外文期刊>Transplantation: Official Journal of the Transplantation Society >Kidney transplantation after liver transplantation from the same donor: four cases of successful steroid withdrawal.
【24h】

Kidney transplantation after liver transplantation from the same donor: four cases of successful steroid withdrawal.

机译:来自同一供体的肝移植后的肾脏移植:成功撤离类固醇四例。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Administration of corticosteroids to kidney recipients has hampered the complete clinical success of kidney transplantation. Because most organ transplantation in Japan is living-related, we had the experience of performing kidney transplantation (KT) after liver transplantation (LT) from the same donor in four patients and successfully withdrew corticosteroid administration. METHODS: Three pediatric and one adult patient received kidney allografts from 3 to 10 months after LT from the same donor. The immunosuppressive regimen consisted of a corticosteroid and tacrolimus. The steroid was withdrawn after KT in all four patients. After complete withdrawal of the steroid, DNA was extracted from two recipients and examined by polymerase chain reaction to detect microchimerism. A mixed lymphocyte reaction (MLR) and cell-mediated lymphocytotoxicity assay (CML) were performed to test for donor-specific hyporesponsiveness. RESULTS: Steroid withdrawal was successfully accomplished after KT in every patient. No steroid-withdrawal-associated complications were observed. In the three pediatric patients, remarkable catch-up growth was observed after steroid withdrawal. In the two patients tested, donor DNA was not detected by polymerase chain reaction, suggesting the absence of microchimerism. MLR and CML showed that recipient lymphocytes reacted against donor lymphocytes at the same level as against the third-party lymphocytes. CONCLUSION: Steroid withdrawal was successfully achieved in four kidney recipients who had received a liver allograft from the same donor. The MLR and CML findings indicated the absence of donor-specific hyporesponsiveness in vitro. Although the precise mechanism is not yet clear, KT after LT from the same donor should be considered as a method that allows steroids to be withdrawn from the immunosuppressive regimen of KT.
机译:背景:对肾接受者使用皮质类固醇激素已经阻碍了肾脏移植的全部临床成功。由于日本大多数器官移植都与生命有关,因此我们有四名患者在同一位供者的肝移植(LT)后进行肾脏移植(KT)的经验,并成功撤出了皮质类固醇激素。方法:三名儿科患者和一名成年患者在同一个供体的LT术后3至10个月接受了肾脏同种异体移植。免疫抑制方案由皮质类固醇和他克莫司组成。在所有四名患者中,KT后均停用了类固醇。类固醇完全撤出后,从两个受体中提取DNA,并通过聚合酶链反应检查以检测微嵌合体。进行混合淋巴细胞反应(MLR)和细胞介导的淋巴细胞毒性试验(CML),以测试供体特异性低反应性。结果:每位患者接受KT后均成功完成类固醇戒断。没有观察到类固醇戒断相关并发症。在三名儿科患者中,类固醇戒断后观察到明显的追赶性生长。在接受测试的两名患者中,未通过聚合酶链反应检测到供体DNA,表明不存在微嵌合体。 MLR和CML表明,受体淋巴细胞对供体淋巴细胞的反应与对第三方淋巴细胞的反应相同。结论:在从同​​一供者处接受肝脏同种异体移植的四位肾脏接受者中,类固醇成功撤离。 MLR和CML的发现表明体外没有供体特异性低反应性。尽管尚不清楚确切的机制,但应考虑将来自同一供体的LT后的KT作为允许从KT免疫抑制方案中撤出类固醇的方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号